Who is sponsoring NCT06017843?

NCT06017843 is sponsored by Centre for Global Public Health Pakistan.

What drugs are being tested in NCT06017843?

Interventions in NCT06017843: Camps site selection for active case finding for TB using MATCH-AI.

What condition does NCT06017843 study?

NCT06017843 studies Tuberculosis.

Is NCT06017843 still recruiting?

NCT06017843 is currently recruiting now. Last updated 25 July 2024.

Last reviewed 2024-07-25 · How we verify

NCT06017843: SPOT-TB

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding

Recruiting now NA Last updated 25 July 2024

What this trial tests

NA trial testing Camps site selection for active case finding for TB using MATCH-AI in Tuberculosis in 180,000 participants. Currently enrolling.

Timeline

1 September 2023

Primary endpoint
31 October 2024

30 June 2025

Quick facts

Lead sponsor	Centre for Global Public Health Pakistan
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	health services research
Enrollment	180,000
Start date	1 September 2023
Primary completion	31 October 2024
Estimated completion	30 June 2025
Sites	1 location across Pakistan

Drugs / interventions tested

Camps site selection for active case finding for TB using MATCH-AI

Conditions studied

Tuberculosis — all drugs for Tuberculosis →

Sponsor

Centre for Global Public Health Pakistan

Who can join

15 and older, any sex, with Tuberculosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this pragmatic, stepped wedge cluster-randomized trial is to measure the comparative yield (number of incident TB cases diagnosed during active case-finding camps) using a site selection approach based on predictions generated via an artificial intelligence software called MATCH-AI (intervention group) versus the conventional approach of camp site selection using field-staff knowledge and experience (control group). The trial will help inform whether a targeted approach towards screening for TB using artificial-intelligence can improve yields of TB cases detected through community-based active case-finding.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Geographical targeting of active case finding for tuberculosis in Pakistan using hotspots identified by artificial intelligence software (SPOT-TB): study protocol for a pragmatic stepped wedge cluster randomised control trial.
Zaidi SMA, Mahfooz A, Latif A, Nawaz N, et al · · 2024 · cited 4× · PMID 38991950 · DOI 10.1136/bmjresp-2023-002079
Geographical targeting of active case finding for tuberculosis in Pakistan using artificial intelligence software (SPOT-TB): a pragmatic stepped wedge cluster randomized control trial
Mahfooz A, Latif A, Asad Zaidi SM, Ahmed W, et al · · 2026 · DOI 10.64898/2026.05.20.26348577

Verify or expand the search:

Other recruiting trials for Tuberculosis

Currently open trials in the same condition.

NCT05917210 — Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda · NA · recruiting
NCT07170735 — Quantitative Measurement of Plasma and Urine MTB Cell-free DNA Level · recruiting
NCT07484490 — Effects of the Active Cycle of Breathing Technique With and Without Balloon Blowing Therapy in Tuberculosis · NA · recruiting
NCT06318416 — Precision Rifampin Trial for Personalized Dosing · Phase 1 · recruiting
NCT07170800 — A Phase 2b Clinical Study of JDB0131 Benzenesulfonate Tablets · Phase 2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06017843 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre for Global Public Health Pakistan
Last refreshed: 25 July 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06017843.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing